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PS56.
Clinical Outcomes and Aortic Architectural Changes
following TEVAR for Chronic Type B Thoracic Aortic
Dissection
Iden D. Andacheh, Karen Kim, Rodney White, Carlos
Donayre, Joe Chauvupun. Surgery, Harbor-UCLA Medi-
cal Center, Los Angeles, CA
Objectives: Review patient outcomes and assess aor-
tic volumetric changes following TEVAR for patients
with complicated chronic type B thoracic aortic
dissection.
Methods: 60 consecutive patients were treated at a
single institution from 2002 to 2009. Indications included:
aneurysmal enlargement (n51), failure of medical man-
agement (n7), and perforation (n1). 3-D CT recon-
structions during patient follow-up were analyzed for
changes in aortic volume and diameter.
Results: TEVAR was successfully performed in 98% of
all patients. The 30-day mortality rate was 19%; six were
procedure-related and four were cardiac events. Post-op
complication rate was 5%; there was one stroke and one
patient with spinal cord ischemia. Seven patients (12%)
required secondary procedure; four for endoleak and three
for persistent distal perfusion.
Conclusions: TEVAR is being considered as an appro-
priate treatment for complicated chronic type B dissection.
Following TEVAR, aortic remodeling occurs with a pre-
dictable linear expansion of the true lumen and regression
of the false lumen. Any deviation from this model suggests
endoleak or persistent distal perfusion. Patient outcomes
from increasing infrarenal aortic diameter and volume need
further investigation.
Table 1. Aortic Dimensional Change From Pre-Op
Time from Intervention
1
Month
3
Months
6
Months
1
Year
Change in Maximal Aortic Diameter
(All patients) 5% 5% 2% 2%
Change in Maximal Infrarenal
Diameter (patients with
dissection below renal arteries) 5% 10% N/A 18%
Change in Maximal Infrarenal
Diameter (patients without
dissection below renal arteries) 0.7% 5% N/A 4%
Infrarenal Total Volume Change
(patients with dissection below
renal arteries) 9% 13% 20% 22%
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The Pathogenesis of Primary Aortoenteric Fistula after
EVAR
Mazin Foteh, Gregory A. Stanley, Sumona Smith, Billy
Kim, Damon Pierce, G. P. Clagett. University of Texas
Southwestern Medical Center, Dallas, TX
Objectives: Secondary aortoenteric fistula (AEF) is an
uncommon, but well described complication of open ab-
dominal aortic aneurysm (AAA) repair, occurring in up to
4% of patients undergoing this procedure. The incidence of
this complication after endovascular aneurysm repair
(EVAR) is less than 1%. Many etiologies of secondary AEF
after EVAR have been proposed including caudal graft
migration, structurally compromised grafts, mechanical
erosion, and complicated endoleaks leading to aneurysm
sac enlargement. Primary AEF after EVAR has not been
widely reported.We propose that hematogenous secondary
graft infection after EVAR is the mechanism for subsequent
primary AEF.
Methods: This study retrospectively reviewed the
charts of five patients presenting at our institution with
infected EVAR stent grafts and AEF. Demographic, labo-
ratory, imaging, and operative data were compiled for
evaluation.
Results: Five patients with a mean age of 69 years
(range 60-76) had computed tomographic evidence of
aortoduodenal fistula occurring a mean of 8.8 months
(range 4-15) after EVAR. All patients were found to have
infectious problems at or before presentation with AEF
including pneumonia, periodontal abscess, wound infec-
tion, ischemic colitis, diverticulitis, and inflammatory
bowel disease. Four patients underwent endograft explant
with neoaortoiliac system (NAIS) reconstruction and duo-
denal repair or resection; one patient refused surgery. At
operation, the aneurysm sac was markedly inflamed with
communication to the overlying duodenum without me-
chanical erosion of the EVAR device. Cultures of two
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